Enzon Pharmaceuticals (ENZN)
Enzon Pharmaceuticals Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -1.071M | -5.021M | -9.105M | -7.068M | 0.431M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 1.443M | 3.097M | 1.582M | 1.315M | 1.509M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 0.616M | 0.331M | 0.622M | 0.759M | 1.187M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 2.059M | 3.428M | 2.204M | 2.074M | 2.696M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | -1.484M | -2.43M | 3.193M | -1.046M | -2.081M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Operating Activities | -0.496M | -4.023M | -3.708M | -6.04M | 1.046M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -0.073M | -0.027M | -0.438M | -0.088M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | -53.77M | -191.61M | 15.72M | 4.09M | 13.19M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Investing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | -53.77M | -191.68M | 15.69M | 3.652M | 13.11M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | -3.863M | -5.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||
| Equity Issued | 0.015M | 0.037M | -24.59M | -49.47M | -41.06M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | 0.00 | -0.261M | -0.21M | -0.684M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Net Cash from Financing Activities | -3.848M | -4.963M | -24.85M | -49.68M | -41.74M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Change in Cash & Cash Equivalents | -58.11M | -200.67M | -12.87M | -52.07M | -27.59M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 104.32M | 397.53M | 104.32M | 305.00M | 317.87M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 46.21M | 104.32M | 305.00M | 317.87M | 369.94M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
